Literature DB >> 7937134

Formation of a stable complex between the human immunodeficiency virus integrase protein and viral DNA.

C Vink1, R A Lutzke, R H Plasterk.   

Abstract

The integrase (IN) protein of the human immunodeficiency virus (HIV) mediates two distinct reactions: (i) specific removal of two nucleotides from the 3' ends of the viral DNA and (ii) integration of the viral DNA into target DNA. Although IN discriminates between specific (viral) DNA and nonspecific DNA in physical in vitro assays, a sequence-specific DNA-binding domain could not be identified in the protein. A nonspecific DNA-binding domain, however, was found at the C terminus of the protein. We examined the DNA-binding characteristics of HIV-1 IN, and found that a stable complex of IN and viral DNA is formed in the presence of Mn2+. The IN-viral DNA complex is resistant to challenge by an excess of competitor DNA. Stable binding of IN to the viral DNA requires that the protein contains an intact N-terminal domain and active site (in the central region of the protein), in addition to the C-terminal DNA-binding domain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937134      PMCID: PMC331896          DOI: 10.1093/nar/22.20.4103

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  52 in total

1.  A rapid in vitro assay for HIV DNA integration.

Authors:  R Craigie; K Mizuuchi; F D Bushman; A Engelman
Journal:  Nucleic Acids Res       Date:  1991-05-25       Impact factor: 16.971

2.  Inversion of the phosphate chirality at the target site of Mu DNA strand transfer: evidence for a one-step transesterification mechanism.

Authors:  K Mizuuchi; K Adzuma
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

3.  DNase protection analysis of the stable synaptic complexes involved in Mu transposition.

Authors:  M Mizuuchi; T A Baker; K Mizuuchi
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

4.  Reversal of integration and DNA splicing mediated by integrase of human immunodeficiency virus.

Authors:  S A Chow; K A Vincent; V Ellison; P O Brown
Journal:  Science       Date:  1992-02-07       Impact factor: 47.728

5.  HIV-1 DNA integration: mechanism of viral DNA cleavage and DNA strand transfer.

Authors:  A Engelman; K Mizuuchi; R Craigie
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

6.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

7.  Site-specific hydrolysis and alcoholysis of human immunodeficiency virus DNA termini mediated by the viral integrase protein.

Authors:  C Vink; E Yeheskiely; G A van der Marel; J H van Boom; R H Plasterk
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

8.  Localization of DNA binding activity of HIV-1 integrase to the C-terminal half of the protein.

Authors:  A M Woerner; M Klutch; J G Levin; C J Marcus-Sekura
Journal:  AIDS Res Hum Retroviruses       Date:  1992-02       Impact factor: 2.205

9.  Substrate specificity of recombinant human immunodeficiency virus integrase protein.

Authors:  R L LaFemina; P L Callahan; M G Cordingley
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

10.  Structural aspects of a higher order nucleoprotein complex: induction of an altered DNA structure at the Mu-host junction of the Mu type 1 transpososome.

Authors:  B D Lavoie; B S Chan; R G Allison; G Chaconas
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  26 in total

1.  Repair of gaps in retroviral DNA integration intermediates.

Authors:  K E Yoder; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Comparison of multiple molecular dynamics trajectories calculated for the drug-resistant HIV-1 integrase T66I/M154I catalytic domain.

Authors:  Alessandro Brigo; Keun Woo Lee; Gabriela Iurcu Mustata; James M Briggs
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

3.  Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.

Authors:  D Esposito; R Craigie
Journal:  EMBO J       Date:  1998-10-01       Impact factor: 11.598

4.  Functional interactions of the HHCC domain of moloney murine leukemia virus integrase revealed by nonoverlapping complementation and zinc-dependent dimerization.

Authors:  F Yang; O Leon; N J Greenfield; M J Roth
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

5.  The role of manganese in promoting multimerization and assembly of human immunodeficiency virus type 1 integrase as a catalytically active complex on immobilized long terminal repeat substrates.

Authors:  A L Wolfe; P J Felock; J C Hastings; C U Blau; D J Hazuda
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

6.  Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.

Authors:  M D Miller; C M Farnet; F D Bushman
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  A three-dimensional model of the human immunodeficiency virus type 1 integration complex.

Authors:  Jerome Wielens; Ian T Crosby; David K Chalmers
Journal:  J Comput Aided Mol Des       Date:  2005-05       Impact factor: 3.686

8.  Differential multimerization of Moloney murine leukemia virus integrase purified under nondenaturing conditions.

Authors:  Rodrigo A Villanueva; Colleen B Jonsson; Jennifer Jones; Millie M Georgiadis; Monica J Roth
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

9.  Coordinated disintegration reactions mediated by Moloney murine leukemia virus integrase.

Authors:  G A Donzella; C B Jonsson; M J Roth
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Mechanistic and pharmacological analyses of HIV-1 integration.

Authors:  Alan Engelman
Journal:  Methods       Date:  2009-04       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.